Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 16, 2017 - Issue 3
Submit an article Journal homepage
723
Views
17
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Safety evaluation of apremilast for the treatment of psoriasis

A. DattolaDepartment of Dermatology, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
View further author information
,
E. Del DucaDepartment of Dermatology, University of Rome “Tor Vergata”, Rome, ItalyView further author information
,
R. SaracenoDepartment of Dermatology, University of Rome “Tor Vergata”, Rome, ItalyView further author information
,
T. GramicciaDepartment of Dermatology, University of Rome “Tor Vergata”, Rome, ItalyView further author information
&
L. BianchiDepartment of Dermatology, University of Rome “Tor Vergata”, Rome, ItalyView further author information
Pages 381-385 | Received 01 Aug 2016, Accepted 26 Jan 2017, Published online: 07 Feb 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Vishalakshi Viswanath, Pradnya Joshi, Prakash Lawate, Dakshata Tare, Dhiraj Dhoot, Namrata Mahadkar & Hanmant Barkate. (2022) An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India. Psoriasis: Targets and Therapy 12, pages 53-61.
Read now
Celina Dubin, Ester Del Duca & Emma Guttman-Yassky. (2020) Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges. Therapeutics and Clinical Risk Management 16, pages 1319-1332.
Read now
Alen Zabotti, Delia Goletti, Ennio Lubrano & Fabrizio Cantini. (2020) The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis. Expert Opinion on Drug Safety 19:1, pages 69-82.
Read now
Masutaka Furue, Takafumi Kadono, Gaku Tsuji & Takeshi Nakahara. (2017) Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis. Expert Opinion on Investigational Drugs 26:12, pages 1403-1408.
Read now
Uwe Wollina. (2017) Emerging treatments for pyoderma gangrenosum. Expert Opinion on Orphan Drugs 5:10, pages 827-832.
Read now

Articles from other publishers (12)

Riley K. Spencer, Kareem G. Elhage, Joy Q. Jin, Mitchell S. Davis, Marwa Hakimi, Tina Bhutani & Wilson Liao. (2023) Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis. Dermatology and Therapy 13:2, pages 437-451.
Crossref
Nicoletta Bernardini, Nevena Skroza, Anna Marchesiello, Alessandra Mambrin, Ilaria Proietti, Ersilia Tolino, Patrizia Maddalena, Federica Marraffa, Giovanni Rossi, Salvatore Volpe & Concetta Potenza. (2022) Psoriatic patients with a history of cancer: A real‐life experience with Apremilast treatment for 104 weeks. Dermatologic Therapy 35:10.
Crossref
Qi Zhang, Ang Li, Yizhen Yan, Yanyang Wu & Xiangyang Zhang. (2021) Systematic thermodynamic analysis of apremilast polymorphs via solubility measurement with modeling: Mechanism evaluation through molecular simulation. European Journal of Pharmaceutical Sciences 165, pages 105958.
Crossref
Andrew D. Price, Vanya D. Wagler, Chase Donaldson & Patrick J. Mastin. (2021) The Effects of Apremilast Therapy on Deployability in Active Duty US Army Soldiers With Plaque Psoriasis and Psoriatic Arthritis. JCR: Journal of Clinical Rheumatology 27:3, pages 127-128.
Crossref
Nafise Yazdanian, Samaneh Mozafarpoor & Azadeh Goodarzi. (2020) Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review. Dermatologic Therapy 34:1.
Crossref
Eleftherios Ntouniadakis & Fredrik Landström. (2020) Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast. Case Reports in Dermatology 12:3, pages 275-281.
Crossref
F. Schein, J.B. Gaultier, M. Dutour, L. Carneiro-Esteves & P. Cathébras. (2020) Périartérite noueuse survenant à l’arrêt d’un traitement par apremilast. La Revue de Médecine Interne 41, pages A155-A156.
Crossref
Ester Del Duca, Paola Morelli, Luigi Bennardo, Cosimo Di Raimondo & Steven Paul Nisticò. (2020) Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. International Journal of Molecular Sciences 21:22, pages 8436.
Crossref
Giacomo Dal Bello, Paolo Gisondi, Luca Idolazzi & Giampiero Girolomoni. (2020) Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review. Rheumatology and Therapy 7:2, pages 271-285.
Crossref
Saori Takamura, Sora Sugai, Ryokichi Taguchi & Yuichi Teraki. (2019) Combination therapy of apremilast and biologics in patients with psoriasis showing biologic fatigue. The Journal of Dermatology 47:3, pages 290-294.
Crossref
Annie Langley & Jennifer Beecker. (2017) Management of Common Side Effects of Apremilast. Journal of Cutaneous Medicine and Surgery 22:4, pages 415-421.
Crossref
Fernando Valenzuela, Javier Fernández & Pablo Santa María. (2018) Update on Oral Therapy for Psoriasis. Current Dermatology Reports 7:1, pages 52-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.